Cyclophosphamide Structural Formula.jpg (Image 01)
Cyclophosphamide Injection
Product Images NDC 0338-9779
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 0338-9779). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Container Label Ndc 0338-9777-01.jpg (Image 02)
Carton Label Ndc 0338-9777-01.jpg (Image 03)
This text provides detailed information about a medication called Cyclophosphamide Injection, including dosing instructions, storage requirements, dilution guidelines, and manufacturer details. It is available in a 500 mg/2.5 mL strength and must be diluted before intravenous use. The medication is sterile, nonpyrogenic, and preservative-free, and the container closure does not contain natural rubber latex. The recommended dilution concentrations for intravenous infusion and direct injection are specified, along with storage instructions in a refrigerated environment.*
Container Label Ndc 0338-9779-01.jpg (Image 04)
Carton Label Ndc 0338-9779-01.jpg (Image 05)
This text provides information on cyclophosphamide injection, which is used for intravenous infusion and direct injection. It includes details on dilution concentrations, recommended dosages, storage conditions, and components of the solution. The product is a sterile, nonpyrogenic, and preservative-free multiple-dose vial requiring refrigeration. It emphasizes the necessity of dilution before intravenous use, contains warnings regarding hazardous drug handling, and specifies the manufacturer as Baxter Healthcare Corporation.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
